Trial Profile
Study of combination chemotherapy of Albumin-bound paclitaxel / Cyclophosphamide in recurrent or metastatic breast cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 21 Jan 2013 New trial record